NFKB1 and Parkinson disease: Significantly reduced NFKB1 expression has been observed in Parkinson’s disease patient samples, and NFKB1 knockout (NFKB1−/−) mice exhibit exacerbated microglial activation and dopaminergic neuron loss [12].